Hybrid membrane-derived nanoparticles for isoliquiritin enhanced glioma therapy

HIGHLIGHTS

  • who: Wenwan Shi et al. from the Department of Pharmaceutics, School of Pharmacy, Centre for Nano Drug/Gene Delivery and, Jiangsu University, Zhenjiang, China have published the research work: Hybrid Membrane-Derived Nanoparticles for Isoliquiritin Enhanced Glioma Therapy, in the Journal: Pharmaceuticals 2022, 15, 1059. of 31/07/2022
  • how: In this paper polyethylene glycol (PEG) 2000 was used to induce cell fusion which PEGylation of the membrane during this process has the potential to further increase the circulating half-life.

SUMMARY

    Isoliquiritin (ISL) is a natural chalcone extracted from licorice . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?